Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00048958
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2021-08-17
First Post:
2002-11-12
Brief Title:
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Study Overview
Official Title:
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia AML Acute Lymphoblastic Leukemia ALL Myelodysplastic Syndrome MDS or Multiple Myeloma MM Patients
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chromosomal analysis or the study of genetic differences in patients previously untreated with AML ALL MDS or MM may be helpful in the diagnosis and classification of disease It may also improve the ability to predict the course of disease and the selection of therapy Institutions must have either an Alliance-approved cytogeneticist or an agreement from an Alliance-approved main member cytogenetics laboratory to enroll a patient on CALGB 8461 The Alliance Approved Institutional Cytogeneticists list is posted on the Alliance for Clinical Trials in Oncology website
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 3U24CA114725-09S1 | NIH | PDQ Physician Data Query | httpsreporternihgovquickSearch3U24CA114725-09S1 |
| NCI-2009-00494 | REGISTRY | None | None |
| CDR0000256897 | REGISTRY | None | None |